These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11725727)

  • 21. Pharmacological approaches to intervention.
    Guy-Grand B
    Int J Obes Relat Metab Disord; 1997 Mar; 21 Suppl 1():S22-4. PubMed ID: 9130037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of anti-obesity drugs in children and adolescents: systematic review and meta-analysis.
    Viner RM; Hsia Y; Tomsic T; Wong IC
    Obes Rev; 2010 Aug; 11(8):593-602. PubMed ID: 19922432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment.
    Van Gaal LF; Wauters MA; De Leeuw IH
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():35-40. PubMed ID: 9792480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible anti-obesity therapeutics from nature--a review.
    Yun JW
    Phytochemistry; 2010 Oct; 71(14-15):1625-41. PubMed ID: 20732701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapy of obesity: an update.
    Schurgin S; Siegel RD
    Nutr Clin Care; 2003; 6(1):27-37. PubMed ID: 12841428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modern medical management of obesity: the role of pharmaceutical intervention.
    Aronne LJ
    J Am Diet Assoc; 1998 Oct; 98(10 Suppl 2):S23-6. PubMed ID: 9787732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New and emerging drug molecules against obesity.
    George M; Rajaram M; Shanmugam E
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):65-76. PubMed ID: 24064009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity.
    Bays HE; Gadde KM
    Drugs Today (Barc); 2011 Dec; 47(12):903-14. PubMed ID: 22348915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological treatment of obesity: present status.
    Scheen AJ; Lefébvre PJ
    Int J Obes Relat Metab Disord; 1999 Feb; 23 Suppl 1():47-53. PubMed ID: 10193862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological management of obesity.
    Hanif MW; Kumar S
    Expert Opin Pharmacother; 2002 Dec; 3(12):1711-8. PubMed ID: 12472368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Obesity: principles of drug therapy].
    Imoberdorf R; Ballmer PE
    Ther Umsch; 2000 Aug; 57(8):522-5. PubMed ID: 11026090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic review of the clinical efficacy of sibutramine and orlistat in weigth loss, quality of life and its adverse effects in obese adolescents.
    García Díaz E; Martín Folgueras T
    Nutr Hosp; 2011; 26(3):451-7. PubMed ID: 21892560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the metabolic effects of controlled-release Phentermine/Topiramate.
    Kiortsis DN
    Hormones (Athens); 2013; 12(4):507-16. PubMed ID: 24457398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orlistat and sibutramine beyond weight loss.
    Mannucci E; Dicembrini I; Rotella F; Rotella CM
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):342-8. PubMed ID: 17928208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medications for weight reduction.
    Bray GA
    Med Clin North Am; 2011 Sep; 95(5):989-1008. PubMed ID: 21855704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacotherapy for obesity: current drugs and those in advanced development.
    Halford JC
    Curr Drug Targets; 2004 Oct; 5(7):637-46. PubMed ID: 15473253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weight management and current options in pharmacotherapy: orlistat and sibutramine.
    Leung WY; Thomas GN; Chan JC; Tomlinson B
    Clin Ther; 2003 Jan; 25(1):58-80. PubMed ID: 12637112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and novel approaches to the drug therapy of obesity.
    Chaput JP; Tremblay A
    Eur J Clin Pharmacol; 2006 Oct; 62(10):793-803. PubMed ID: 16937118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.